?-To The Moon - Tiger Brokers Online Investing Community

Like
1
Favorite

53570b80
2021-05-10

In the second half of the year, will the medical fund become the most beautiful "cub"?

自今年2月沪深300大幅下挫以来，市场一直维持震荡行情。不过，五一劳动节前的一波市场行情，让不少明星基金产品重新回到大众的视野当中。随着货币市场及财政政策的逐渐明朗，总体来看，公募基金下半年不会面临

In the second half of the year, will the medical fund become the most beautiful "cub"?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

Top
Latest

53570b80
·2021-05-10
确实大大问号疫情和估值让医药股在云端可高可低
Reply
Like
Report

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":190323474,"tweetId":"190323474","gmtCreate":1620601480698,"gmtModify":1704345213168,"author":{"id":3577397803511360,"idStr":"3577397803511360","authorId":3577397803511360,"authorIdStr":"3577397803511360","name":"53570b80","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":13,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>?</body></html>","htmlText":"<html><head></head><body>?</body></html>","text":"?","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/190323474","repostId":1133792628,"repostType":4,"repost":{"id":"1133792628","kind":"news","pubTimestamp":1620435850,"share":"https://ttm.financial/m/news/1133792628?lang=en_US&edition=fundamental","pubTime":"2021-05-08 09:04","market":"sh","language":"zh","title":"In the second half of the year, will the medical fund become the most beautiful \"cub\"?","url":"https://stock-news.laohu8.com/highlight/detail?id=1133792628","media":"苏宁金融研究院","summary":"自今年2月沪深300大幅下挫以来，市场一直维持震荡行情。不过，五一劳动节前的一波市场行情，让不少明星基金产品重新回到大众的视野当中。\n随着货币市场及财政政策的逐渐明朗，总体来看，公募基金下半年不会面临","content":"Since the CSI 300 fell sharply in February this year, the market has remained volatile. However, a wave of market conditions before May Day has brought many star fund products back to the public's field of vision.With the gradual clarity of the money market and fiscal policy, on the whole, Public Offering of Fund will not face the pressure of large-scale redemption in the second half of the year, but it is necessary to be alert to the rebound of the market, which will cause Christians to choose to redeem and stop losses one after another, weakening the rebound. The author predicts that the pharmaceutical industry will become the focus in the second half of the year.1.Pharma funds outperform marketBased on February 10, 2021, the author selected Zhang Kun's E Fund small and medium-sized cap, Yuan Fang's ICBC Credit Suisse Culture and Sports Industry A, and Gulen's China Europe Medical and Health A for analysis.<img src=\"https://static.tigerbbs.com/7b2d09162501d8a0dcfd87bacc0ec9d4\" tg-width=\"569\" tg-height=\"317\" referrerpolicy=\"no-referrer\">It can be found that, except for Zhang Kun's E Fund's small and medium-sized caps that underperformed the CSI 300, Yuan Fang's ICBC Credit Suisse Culture and Sports Industry and Gulen's CEIBS Medical and Health have both outperformed the CSI 300, and their net values after restoration have reached February 2021. About 93% of the highest point on March 10. Looking through the quarterly report of China Europe Medical and Health, faced with such excellent results, Gulen only made a brief summary: We have generally maintained a high position operation, and in the long-term optimistic innovative drug industry chain, medical services, and high-quality generic drugs. Leading enterprises and other directions have focused on layout.Choosing a fund and a good industry is crucial. What is the growth of the pharmaceutical industry itself? The author selects the most commonly used comparative index of pharmaceutical funds as the CSI Medical and Health Index, and compares it with the CSI 300 Index: From a performance perspective, the CSI Medical and Health Index outperforms the CSI 300 Index in both short-term and medium-and long-term. In terms of volatility, the volatility of the CSI Medical and Health Index is generally higher than that of the CSI 300 Index. For Christians with a slightly higher risk appetite, the CSI Pharmaceutical Index seems to be a better choice than the CSI 300 Index.Note: Statistics are as of April 30th this year. In order to exclude the impact of dividends, consistent with the index calculation caliber, CEIBS Medical Health A is the unit net value data.Compared with the CSI Medical and Health Index, the China-Europe Medical and Health Fund managed by Gulen has outstanding fund managers' active management capabilities. Since 2017, this fund has more than tripled its income, far exceeding the CSI Medical and Health Index. Whether during the market valuation inflation or during the recent market decline and shock, Gulen's China Europe Healthcare A outperformed the benchmark. Overall, Gulen is an excellent fund manager who has crossed bulls and bears.<img src=\"https://static.tigerbbs.com/c38d95f77d0b8f5ff0b88ccdcce90782\" tg-width=\"578\" tg-height=\"289\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/acde296784ae353b1dba659233e5cd2e\" tg-width=\"569\" tg-height=\"288\" referrerpolicy=\"no-referrer\">So, where is the current pharmaceutical industry? At present, the overall PE (TTM) of the pharmaceutical industry is at a historically high level, but compared with the PE (TTM) of the CSI 300, the pharmaceutical industry as a whole is in a relatively stable range.<img src=\"https://static.tigerbbs.com/0c7556cf3745a752c3f7bce4d9c79b8a\" tg-width=\"560\" tg-height=\"397\" referrerpolicy=\"no-referrer\">Two,Two \"certainties\" in the pharmaceutical industryThe performance of the pharmaceutical sector is outstanding, and the pharmaceutical theme fund is even more \"dancing in the wind\". And the medical industry, both in the short and long term, has strong certainty.In the short term, COVID-19 pandemic will bring \"certainty\".Judging from the situation of vaccination and new cases in the United States, Japan and South Korea, the current number of COVID-19 vaccine vaccinations per 100 people in Japan and South Korea is relatively low. Since the popularization of vaccines began in February this year, the number of new cases and vaccinations on that day has grown at the same time. The vaccine penetration rate in the United States is relatively high, with nearly 75 doses per 100 people vaccinated, and the number of new cases on that day is also in a downward trend. However, it is worth noting that there were still more than 30,000 new cases in the United States that day, and the effectiveness of the vaccine cannot be verified in the short term.<img src=\"https://static.tigerbbs.com/745fd514ff5d0460acb694577f689a78\" tg-width=\"537\" tg-height=\"336\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/bde10b6b5c6ec98c8dba78b95c3dc89e\" tg-width=\"541\" tg-height=\"330\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/85e49685e09d55bfb31130ef969034de\" tg-width=\"537\" tg-height=\"331\" referrerpolicy=\"no-referrer\">Moreover, regarding the situation in virus mutation, there is still no effective control means, and the global epidemic will not improve much in the short term. In the future, all countries will continue to increase investment in medical care.In view of the fact that major foreign medical supplies producing countries and developing countries are plagued by the epidemic, the short-term certainty of China's medical supplies exports is expected to become medium-and long-term certainty.In the long run, the aging of China's population will also bring \"certainty\".The results of the 7th census are yet to be announced. However, there is no doubt that the aging problem of China's population is becoming more and more prominent.Available data show that by the end of 2019, my country's population aged 65 and above had reached 176 million, an increase of 9.45 million compared with 2018. At the same time, my country's average life expectancy reached 77.3 years in 2019, but the average healthy life expectancy was only 68.7 years, with an average survival time of more than 8 years with illness.At present, China's total health expenditure accounts for 5.2% of GDP, far lower than the world average of 9.9%. With the gradual upgrading of medical conditions, chronic diseases will receive more and more attention, and chronic diseases are highly dependent on drugs and medical treatment, which will effectively promote the development of the medical industry. From this perspective, pharmaceutical funds are still the focus in the second half of the year.Three,Which medical funds can be boughtIn the future, which medical funds<a href=\"https://laohu8.com/S/300785\">Worth buying</a>What about it?The following are actively managed funds with pharmaceutical and medical themes that have been established for more than 2 years, with a scale of more than 1 billion, and an annualized rate of more than 20%, for your reference:<img src=\"https://static.tigerbbs.com/0c7f73e70451f092cb598b4fefc961fe\" tg-width=\"545\" tg-height=\"519\" referrerpolicy=\"no-referrer\">","source":"lsy1568689437122","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>In the second half of the year, will the medical fund become the most beautiful \"cub\"?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIn the second half of the year, will the medical fund become the most beautiful \"cub\"?\n</h2>\n<h4 class=\"meta\">\n\n苏宁金融研究院2021-05-08 09:04\n\n</h4>\n</header>\n<article>\nSince the CSI 300 fell sharply in February this year, the market has remained volatile. However, a wave of market conditions before May Day has brought many star fund products back to the public's field of vision.With the gradual clarity of the money market and fiscal policy, on the whole, Public Offering of Fund will not face the pressure of large-scale redemption in the second half of the year, but it is necessary to be alert to the rebound of the market, which will cause Christians to choose to redeem and stop losses one after another, weakening the rebound. The author predicts that the pharmaceutical industry will become the focus in the second half of the year.1.Pharma funds outperform marketBased on February 10, 2021, the author selected Zhang Kun's E Fund small and medium-sized cap, Yuan Fang's ICBC Credit Suisse Culture and Sports Industry A, and Gulen's China Europe Medical and Health A for analysis.<img src=\"https://static.tigerbbs.com/7b2d09162501d8a0dcfd87bacc0ec9d4\" tg-width=\"569\" tg-height=\"317\" referrerpolicy=\"no-referrer\">It can be found that, except for Zhang Kun's E Fund's small and medium-sized caps that underperformed the CSI 300, Yuan Fang's ICBC Credit Suisse Culture and Sports Industry and Gulen's CEIBS Medical and Health have both outperformed the CSI 300, and their net values after restoration have reached February 2021. About 93% of the highest point on March 10. Looking through the quarterly report of China Europe Medical and Health, faced with such excellent results, Gulen only made a brief summary: We have generally maintained a high position operation, and in the long-term optimistic innovative drug industry chain, medical services, and high-quality generic drugs. Leading enterprises and other directions have focused on layout.Choosing a fund and a good industry is crucial. What is the growth of the pharmaceutical industry itself? The author selects the most commonly used comparative index of pharmaceutical funds as the CSI Medical and Health Index, and compares it with the CSI 300 Index: From a performance perspective, the CSI Medical and Health Index outperforms the CSI 300 Index in both short-term and medium-and long-term. In terms of volatility, the volatility of the CSI Medical and Health Index is generally higher than that of the CSI 300 Index. For Christians with a slightly higher risk appetite, the CSI Pharmaceutical Index seems to be a better choice than the CSI 300 Index.Note: Statistics are as of April 30th this year. In order to exclude the impact of dividends, consistent with the index calculation caliber, CEIBS Medical Health A is the unit net value data.Compared with the CSI Medical and Health Index, the China-Europe Medical and Health Fund managed by Gulen has outstanding fund managers' active management capabilities. Since 2017, this fund has more than tripled its income, far exceeding the CSI Medical and Health Index. Whether during the market valuation inflation or during the recent market decline and shock, Gulen's China Europe Healthcare A outperformed the benchmark. Overall, Gulen is an excellent fund manager who has crossed bulls and bears.<img src=\"https://static.tigerbbs.com/c38d95f77d0b8f5ff0b88ccdcce90782\" tg-width=\"578\" tg-height=\"289\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/acde296784ae353b1dba659233e5cd2e\" tg-width=\"569\" tg-height=\"288\" referrerpolicy=\"no-referrer\">So, where is the current pharmaceutical industry? At present, the overall PE (TTM) of the pharmaceutical industry is at a historically high level, but compared with the PE (TTM) of the CSI 300, the pharmaceutical industry as a whole is in a relatively stable range.<img src=\"https://static.tigerbbs.com/0c7556cf3745a752c3f7bce4d9c79b8a\" tg-width=\"560\" tg-height=\"397\" referrerpolicy=\"no-referrer\">Two,Two \"certainties\" in the pharmaceutical industryThe performance of the pharmaceutical sector is outstanding, and the pharmaceutical theme fund is even more \"dancing in the wind\". And the medical industry, both in the short and long term, has strong certainty.In the short term, COVID-19 pandemic will bring \"certainty\".Judging from the situation of vaccination and new cases in the United States, Japan and South Korea, the current number of COVID-19 vaccine vaccinations per 100 people in Japan and South Korea is relatively low. Since the popularization of vaccines began in February this year, the number of new cases and vaccinations on that day has grown at the same time. The vaccine penetration rate in the United States is relatively high, with nearly 75 doses per 100 people vaccinated, and the number of new cases on that day is also in a downward trend. However, it is worth noting that there were still more than 30,000 new cases in the United States that day, and the effectiveness of the vaccine cannot be verified in the short term.<img src=\"https://static.tigerbbs.com/745fd514ff5d0460acb694577f689a78\" tg-width=\"537\" tg-height=\"336\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/bde10b6b5c6ec98c8dba78b95c3dc89e\" tg-width=\"541\" tg-height=\"330\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/85e49685e09d55bfb31130ef969034de\" tg-width=\"537\" tg-height=\"331\" referrerpolicy=\"no-referrer\">Moreover, regarding the situation in virus mutation, there is still no effective control means, and the global epidemic will not improve much in the short term. In the future, all countries will continue to increase investment in medical care.In view of the fact that major foreign medical supplies producing countries and developing countries are plagued by the epidemic, the short-term certainty of China's medical supplies exports is expected to become medium-and long-term certainty.In the long run, the aging of China's population will also bring \"certainty\".The results of the 7th census are yet to be announced. However, there is no doubt that the aging problem of China's population is becoming more and more prominent.Available data show that by the end of 2019, my country's population aged 65 and above had reached 176 million, an increase of 9.45 million compared with 2018. At the same time, my country's average life expectancy reached 77.3 years in 2019, but the average healthy life expectancy was only 68.7 years, with an average survival time of more than 8 years with illness.At present, China's total health expenditure accounts for 5.2% of GDP, far lower than the world average of 9.9%. With the gradual upgrading of medical conditions, chronic diseases will receive more and more attention, and chronic diseases are highly dependent on drugs and medical treatment, which will effectively promote the development of the medical industry. From this perspective, pharmaceutical funds are still the focus in the second half of the year.Three,Which medical funds can be boughtIn the future, which medical funds<a href=\"https://laohu8.com/S/300785\">Worth buying</a>What about it?The following are actively managed funds with pharmaceutical and medical themes that have been established for more than 2 years, with a scale of more than 1 billion, and an annualized rate of more than 20%, for your reference:<img src=\"https://static.tigerbbs.com/0c7f73e70451f092cb598b4fefc961fe\" tg-width=\"545\" tg-height=\"519\" referrerpolicy=\"no-referrer\">\n<div class=\"bt-text\">\n\n\n source：<a href=\"https://mp.weixin.qq.com/s/SX5XCz2NmaZk4KFourQInQ\">苏宁金融研究院</a>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/1c17254274c2907ed04a766866b7c3d8","relate_stocks":{"160635":"医药基金"},"source_url":"https://mp.weixin.qq.com/s/SX5XCz2NmaZk4KFourQInQ","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133792628","content_text":"自今年2月沪深300大幅下挫以来，市场一直维持震荡行情。不过，五一劳动节前的一波市场行情，让不少明星基金产品重新回到大众的视野当中。\n随着货币市场及财政政策的逐渐明朗，总体来看，公募基金下半年不会面临大规模赎回的压力，但需要警惕市场的反弹导致基民陆续选择赎回止损，削弱反弹力度。笔者预判，医药行业会成为下半年的关注点。\n一、医药基金跑赢大盘\n以2021年2月10日为基准，笔者选取了张坤的易方达中小盘、袁芳的工银瑞信文体产业A及葛兰的中欧医疗健康A进行分析。\n\n可以发现，除张坤的易方达中小盘跑输沪深300以外，袁芳的工银瑞信文体产业和葛兰的中欧医疗健康都已跑赢沪深300，复权后净值均已经达到了2021年2月10日最高点的93%左右。翻看中欧医疗健康的一季报，面对这样优异的成绩，葛兰只做了简单地概括：我们总体维持了高仓位运作，在长期看好的创新药产业链、医疗服务、高质量仿制药的龙头企业等方向进行了着重布局。\n选基金选好行业很关键。医药行业本身的成长性如何？笔者选取了医药基金最常用的比较指数是中证医药卫生指数，将其与沪深300指数比较：从业绩角度来看，无论是短期还是中长期，中证医药卫生指数都跑赢了沪深300指数。在波动率方面，中证医药卫生指数波动率总体高于沪深300指数。对于风险偏好稍高的基民来说，中证医药指数似乎是比沪深300指数更好的选择。\n注：数据统计截至今年4月30日。为排除分红影响，与指数计算口径一致，中欧医疗健康A为单位净值数据。\n而葛兰掌管的中欧医疗健康基金与中证医药卫生指数相比，基金经理的主动管理能力凸显。2017年至今，这支基金跑出了3倍多的收益，远超中证医药卫生指数。无论是大盘估值膨胀期间，还是近期大盘下挫震荡期间，葛兰的中欧医疗健康A都跑赢了基准。总体来说，葛兰算是穿越牛熊的优秀基金经理了。\n\n那么，现在的医药行业处于什么位置？目前，医药行业整体PE(TTM)处于历史较高水平，但相对于沪深300的PE(TTM)，医药行业整体处于相对稳定的区间。\n\n二、医药行业的两个“确定性”\n医药板块表现突出，医药主题基金更是“乘风起舞”。且医疗行业，不管从短期还是长期来看，确定性都强。\n短期上，新冠疫情会带来“确定性”。\n从美、日、韩三国的疫苗接种与新增病例情况来看，日韩两国当前每百人新冠疫苗接种量较低，自今年2月开始普及疫苗以来，当日新增病例与疫苗接种量同增长。美国疫苗普及率相对较高，每百人接种量接近75剂次，当日新增病例也在震荡下跌的趋势中。但值得注意的是，美国当日新增病例依然超过3万，疫苗的有效性在短期内无法得到验证。\n\n且针对病毒变异情况，目前依然没有有效的控制手段，全球疫情短期内不会有太大的改善。未来，各国都将继续加大对医疗方面的投入。\n鉴于国外主要的医疗物资生产国及发展中国家饱受疫情困扰，中国医疗物资对外出口的短期确定性有望变成中长期确定性。\n长期上，我国人口老龄化也会带来“确定性”。\n第7次人口普查结果有待公布。但，毋庸置疑，中国人口老龄化问题越来越凸显。\n已有的数据显示，截至2019年底，我国65周岁及以上人口已达1.76亿，较2018年新增945万人。与此同时，2019年我国人均预期寿命达77.3岁，但人均健康预期寿命仅为68.7岁，平均有8年多带病生存时间。\n目前，我国卫生总费用占GDP比重为5.2%，远低于世界平均水平的9.9%。随着医疗条件的逐步升级，慢性疾病将越来越受到重视，而慢性疾病对药物和医疗的依赖性极高，这将有力地推动医疗业的发展。从这个角度来看，医药类基金依然是下半年的关注点。\n三、哪些医药基金可买\n未来，哪些医药基金值得买呢？\n以下是成立时间超过2年，规模超过10亿，年化超过20%的医药医疗题材的主动管理型基金，可供大家参考：","news_type":1,"symbols_score_info":{"160635":0.9}},"isVote":1,"tweetType":1,"viewCount":2857,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":4273410,"commentId":"4273410","gmtCreate":1620601625235,"gmtModify":1680787782988,"authorId":3577397803511360,"author":{"id":3577397803511360,"idStr":"3577397803511360","authorId":3577397803511360,"name":"53570b80","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":190323474,"objectIdStr":"190323474","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"确实大大问号 疫情和估值让医药股在云端可高可低","text":"确实大大问号 疫情和估值让医药股在云端可高可低","html":"确实大大问号 疫情和估值让医药股在云端可高可低","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}